FDA / Research

Neurological Symptoms Described in Children With COVID-19

Jul 4, 2020

THURSDAY, July 2, 2020 (HealthDay News) — Children with COVID-19 may present with new...

Hydroxychloroquine Cuts Mortality by 50%

Jul 2, 2020

DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System....

Model May Help Predict Risk for Testing Positive for COVID-19

Jun 26, 2020

THURSDAY, June 25, 2020 (HealthDay News) — It is possible to predict the likelihood of...

Gout Drug Shows Promise for Myocardial Injury in Covid-19 Patients

Jun 25, 2020

Colchicine-treated patients had longer time to clinical deterioration in GRECCO-19 study Patients...

Covid-19: Is There An ’Immunity Shield’ Post-Infection?

Jun 24, 2020

An observational study says ’no,’ suggests neutralizing antibodies in SARS-CoV-2 rapidly fade away...

As Problems Grow With Abbott’s Fast COVID Test, FDA Standards Are Under Fire

Jun 24, 2020

After the FDA issues a public warning about the test, one of its senior officials says point-of-care coronavirus tests can miss 20% of cases and still be considered useful. Public health experts are split.

Blood Type May Play a Role in Covid-19 Severity

Jun 23, 2020

Type O blood linked to lower respiratory failure in study Genetic analysis involving Covid-19...

Covid-19: Study Finds Convalescent Plasma Safe

Jun 23, 2020

Signal promising but efficacy needs to be confirmed Covid-19 convalescent plasma appears safe for...

Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis.

Jun 22, 2020

To assess the overall prevalence of clinical signs, symptoms, and radiological findings in...

Covid-19: FDA Warns Companies Selling Antibody Tests

Jun 19, 2020

Agency cites 3 companies for selling unapproved direct-to-consumer tests WASHINGTON — Three...

Citing COVID, Sutter Pushes To Revisit Landmark Antitrust Settlement

Jun 19, 2020

Six months after agreeing to a $575 million settlement in a landmark antitrust case, Sutter Health has yet to pay a single dollar and now says the terms may be untenable, given the strain caused by the pandemic.